We are live on ! Find out more
SOPH icon

SOPHiA GENETICS

49 hedge funds and large institutions have $120M invested in SOPHiA GENETICS in 2026 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,890% more call options, than puts

Call options by funds: $299K | Put options by funds: $10K

70% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 10

41% more capital invested

Capital invested by funds: $85.5M → $120M (+$34.9M)

38% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 8

17% more funds holding

Funds holding: 4249 (+7)

8.41% more ownership

Funds ownership: 27.1%35.51% (+8.4%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
49
Holders Change
+7
Holders Change %
+16.67%
% of All Funds
0.6%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
17
Increased
11
Reduced
8
Closed
10
Calls
$299K
Puts
$10K
Net Calls
+$289K
Net Calls Change
+$100K
Name Holding Trade Value Shares
Change
Change in
Stake
Polen Capital Management
51
Polen Capital Management
Florida
-$102K -21,738 Closed
FIA
52
FNY Investment Advisers
New York
-$74K -16,010 Closed
XT
53
XTX Topco
Cayman Islands
-$54.9K -11,760 Closed
QC
54
Quadrature Capital
United Kingdom
-$54.4K -11,649 Closed
Acadian Asset Management
55
Acadian Asset Management
Massachusetts
-$27K -5,911 Closed
Bank of America
56
Bank of America
North Carolina
-$25.9K -5,552 Closed
PNC Financial Services Group
57
PNC Financial Services Group
Pennsylvania
-$1.73K -370 Closed
UFPG
58
United Financial Planning Group
New York
-$794 -170 Closed
Simplex Trading
59
Simplex Trading
Illinois
-$151 -31 Closed

SOPH Hedge Fund Activity: Q1 2026 in Review

49 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in SOPHiA GENETICS (SOPH) for Q1 2026, worth a combined $120M — up 41% from $85.5M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new SOPH positions and 10 closed out — a net gain of 7 holders — while 11 added to existing stakes and 8 trimmed.

The largest buyer was Soleus Capital Management, opening a new position worth an estimated $9M. The largest seller was Millennium Management, cutting an estimated $561K.

  • 49 institutional investors held SOPHiA GENETICS (SOPH) as of Q1 2026, up from 42 in Q4 2025.
  • Funds reported $120M of SOPHiA GENETICS stock for Q1 2026, up 41% quarter-over-quarter.
  • 17 funds opened new SOPHiA GENETICS positions in Q1 2026 and 10 closed out, a net change of +7 holders.
  • The largest SOPHiA GENETICS buyer in Q1 2026 was Soleus Capital Management, an estimated $9M added.
  • The largest SOPHiA GENETICS seller in Q1 2026 was Millennium Management, an estimated $561K sold.

Based on aggregated 13F filings for Q1 2026.